These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 8740199)

  • 1. Energy metabolism in the hypothalamus and plasma cortisol levels in patients with schizophrenia.
    Wik G
    Horm Metab Res; 1996 Apr; 28(4):205-6. PubMed ID: 8740199
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of neuroleptic treatment on cortisol and 3-methoxy-4-hydroxyphenylethyl glycol levels in blood.
    Wik G
    J Endocrinol; 1995 Mar; 144(3):425-9. PubMed ID: 7738466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia: an illness of distorted reality.
    Dean B
    Biologist (London); 2000 Sep; 47(4):202-6. PubMed ID: 11153121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine and amisulpride in refractory schizophrenia and alcohol dependence.
    Dervaux A; Cazali J
    J Clin Psychopharmacol; 2007 Oct; 27(5):514-6. PubMed ID: 17873688
    [No Abstract]   [Full Text] [Related]  

  • 5. Alterations of glucose metabolism during treatment with clozapine or amisulpride: results from a prospective 16-week study.
    Rettenbacher MA; Hummer M; Hofer A; Baumgartner S; Ebenbichler C; Edlinger M; Kemmler G; Lechleitner M; Wolfgang Fleischhacker W
    J Psychopharmacol; 2007 Jun; 21(4):400-4. PubMed ID: 17050656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency.
    Chen HK; Chen CK; Tzeng NS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1615-6. PubMed ID: 18597910
    [No Abstract]   [Full Text] [Related]  

  • 7. [Atypical neuroleptics--a heterogenous group. Valuable option in acute psychoses].
    MMW Fortschr Med; 2002 May; Suppl 2():85. PubMed ID: 12070863
    [No Abstract]   [Full Text] [Related]  

  • 8. Schizophrenia.
    Lawrie S; McIntosh A; Nadeem Z
    Clin Evid; 2005 Dec; (14):1306-30. PubMed ID: 16620456
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sulpiride: an atypical neuroleptic with a wide spectrum of therapeutic claims].
    Wasieczko A; Wasieczko Z
    Psychiatr Pol; 1996; 30(6):1009-16. PubMed ID: 9132763
    [No Abstract]   [Full Text] [Related]  

  • 10. Sulpiride--an antipsychotic agent: comparative trial vs. haloperidol.
    Cassano GB; Castrogiovanni P; Conti L; Bonollo L
    Psychopharmacol Bull; 1977 Jul; 13(3):41-3. PubMed ID: 18759
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia.
    Kasper S
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S19-26. PubMed ID: 12685918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
    Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
    Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sulpiride: a neuroleptic agent of new generation with unique pharmacological qualities and rather wide range of clinical applications].
    Pawłowski L
    Psychiatr Pol; 1993; 27(2):199-205. PubMed ID: 8104350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amisulpride--a neuroleptic agent for all phases of schizophrenia].
    Nervenarzt; 1999 Mar; 70(3 Suppl Amisulprid):1-8. PubMed ID: 10221135
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical effectiveness of piperacetazine injection in schizophrenic patients: a controlled study.
    Kulkarni AS
    Adv Biochem Psychopharmacol; 1974; 9(0):691-9. PubMed ID: 4151770
    [No Abstract]   [Full Text] [Related]  

  • 16. Sex difference in effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.
    Wu RR; Zhao JP; Zhai JG; Guo XF; Guo WB
    J Clin Psychopharmacol; 2007 Aug; 27(4):374-9. PubMed ID: 17632222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute weight gain induced by amisulpride monotherapy in a first-episode schizophrenic patient.
    Papadimitriou GN; Theleritis CG; Dikeos DG; Psarros CJ; Soldatos CR
    Int Clin Psychopharmacol; 2006 May; 21(3):181-4. PubMed ID: 16528141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic-induced movement disorders - forgotten but not gone.
    Weiden PJ
    Acta Psychiatr Scand; 2008 Jun; 117(6):401-2. PubMed ID: 18479315
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperglycemia and antipsychotic medications.
    Haupt DW; Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma amisulpride levels in schizophrenia or schizoaffective disorder.
    Bergemann N; Kopitz J; Kress KR; Frick A
    Eur Neuropsychopharmacol; 2004 May; 14(3):245-50. PubMed ID: 15056484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.